Senior insider sale
EVP, Chief Technical Ops. Off. at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.89M
4.25K shares
What this filing means
ATKINSON EDWARD MORROW III plans to sell 4.25K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.89M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2026ACC: 0001959173-26-000853
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
4.25K
Shares to sell
$1.89M
Approx. market value
1.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/10/2026
1.75KTotal acquired1.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2026 | Restricted Stock Vesting Compensation | 1.75K | — |
| Total | 1.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.50K
Market value
$1.09M
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.75K
Market value
$806.2K
2/11/2026
Total
Units
4.25K
Value
$1.89M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2025 | 2.50K | $1.09M | — | Completed |
| Planned — Approximate Date | ||||
2/11/2026 | 1.75K | $806.2K | NASDAQ | Planned |
| Total | 4.25K | $1.89M | ||